Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2002
12/19/2002WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002WO2002070541A3 Peptide deformylase inhibitors
12/19/2002WO2002070533A3 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
12/19/2002WO2002070515A3 Chromane derivatives, process for their preparation and their use as antitumor agents
12/19/2002WO2002066624A3 Novel human protease and polynucleotides encoding the same
12/19/2002WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use
12/19/2002WO2002058626A9 Methods and compositions for the identification and treatment of neurodegenerative disorders
12/19/2002WO2002055542A3 Hpv-specific peptides, which block the binding of hpv to the host cell
12/19/2002WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002WO2002055085A3 Use of an adenosine a3 receptor agonist for inhibition of viral replication
12/19/2002WO2002050082A3 Inhibitors of papilloma virus
12/19/2002WO2002028887A3 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours
12/19/2002WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof
12/19/2002WO2002008287A3 Nk cells activating receptors and their therapeutic and diagnostic uses
12/19/2002WO2001082788A9 Compounds and methods for the treatment and prevention of bacterial infection
12/19/2002WO2001070032A9 Recombinant parainfluenza virus expression systems and vaccines
12/19/2002WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002US20020193729 Microprojection array immunization patch and method
12/19/2002US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002US20020193588 Crystals of penicillin and process for the production thereof
12/19/2002US20020193587 Penicillin crystal and process for producing the same
12/19/2002US20020193571 Wsx receptor agonist antibodies
12/19/2002US20020193560 Cyclic polypeptide compound for use as microbiocide
12/19/2002US20020193410 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
12/19/2002US20020193409 Prodrugs of anticancer agents employing substituted aromatic acids
12/19/2002US20020193396 Sulfonamido ether substituted imidazoquinolines
12/19/2002US20020193369 Antifungal compounds and uses therefor
12/19/2002US20020193360 For enhancing cognition or in the treatment of diseases of cognitive dysfunction including but not limited to Alzheimer's Disease (AD), mild cognitive impairment, age-related cognitive decline, vascular dementia, Parkinson's disease
12/19/2002US20020193354 7, 9-substituted tetracycline compounds
12/19/2002US20020193353 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents
12/19/2002US20020193333 For immunization for the therapy of diseases with or without combination chemotherapy
12/19/2002US20020193318 Administering compound that binds human serum albumin (HSA) to increase free drug levels of the camptothecin compound during anti-topoisomerase I-based therapy in human
12/19/2002US20020193304 Anti-HIV agents
12/19/2002US20020192826 Recombinant AAV vector-based transduction system and use of same
12/19/2002US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002US20020192681 Detection of parasite in sample; obtain sample, isolate nucleotide sequences from dendritic cells, determine gene expression, presence of preferential gene indicates infections
12/19/2002US20020192660 Reducing effect of regulatory sequences on transcription; obtain nucleotide sequences, detect regulatory sequences, mutate, transfect into cell, culture, monitor adjustment in transcription control
12/19/2002US20020192644 Detection of natural killer receptor; obtain samples, incubate with oligonucleotides, detect bound complexes, presence of complexes indicates receptor
12/19/2002US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
12/19/2002US20020192638 Evaluation of cells sensitvity to anticancer agents; obtain tissue, separate, culture tissue, inoculate cells, incubate with anticancer agent, monitor sensitivity to anticancer agents
12/19/2002US20020192297 Hydrogen peroxide disinfectant with increased activity
12/19/2002US20020192285 Controlled release pellet formulation
12/19/2002US20020192282 Multilayer pharmaceutical product for release in the colon
12/19/2002US20020192279 Method for producing antibiotic composites
12/19/2002US20020192237 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
12/19/2002US20020192234 Antigen strain in vehicle; inducting immunology response
12/19/2002US20020192232 Methods and compositions for impairing multiplication of HIV-1
12/19/2002US20020192227 Vaccines against cancer and infectious diseases
12/19/2002US20020192225 Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cadA, to reduce pathogenicity in a bacteria or to combat pathogenic bacterial infections
12/19/2002US20020192217 Methods for regulation of immune responses to conditions involving mediator-induced pathology
12/19/2002US20020192205 Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group A and group C streptococci
12/19/2002US20020192202 Probiotic compounds derived from lactobacillus casei strain KE01
12/19/2002US20020192195 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
12/19/2002US20020192157 Treatment and diagnosis of macrophage mediated disease
12/19/2002CA2487039A1 Combination therapies using vitamin b12 and interferon for treatment of viral, proliferative and inflammatory diseases
12/19/2002CA2487038A1 Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
12/19/2002CA2450628A1 Benzothiophene compounds having antiinfective activity
12/19/2002CA2450625A1 Isoquinoline compounds having antiinfective activity
12/19/2002CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002CA2450131A1 Respiratory syncytial virus
12/19/2002CA2450027A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002CA2449962A1 Use of glycosaminoglycans for the treatment of hiv-associated nephropathy
12/19/2002CA2449944A1 Compositions comprising nitrofurantoin and uva ursi
12/19/2002CA2449934A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002CA2449732A1 Porous sponge-like cellulosic material for treatment of injuries
12/19/2002CA2449593A1 Spray freeze-dried compositions
12/19/2002CA2449544A1 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002CA2449517A1 Tissue-specific endothelial membrane proteins
12/19/2002CA2449272A1 Intracellular signaling molecules
12/19/2002CA2449247A1 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/19/2002CA2449213A1 Ophthalmic compositions comprising hyaluronic acid
12/19/2002CA2447891A1 Exothermic formulations for the treatment of ectoparasites
12/19/2002CA2447687A1 Substituted 1-benzazepines and derivatives thereof
12/19/2002CA2445467A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
12/18/2002EP1267171A1 Cofactor-based screening method for nuclear receptor modulators
12/18/2002EP1267167A1 Method for identifying HCV entry factors
12/18/2002EP1266899A2 Rapamycin hdroxyesters, process for their preparation and pharmaceutical compositions containing them
12/18/2002EP1266662A2 Synthetic peptide vaccines for dental caries
12/18/2002EP1266578A1 Feed preparation for animals, especially for poultry
12/18/2002EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002EP1266012A2 Proteases
12/18/2002EP1266002A2 Il-17 receptor like molecules and uses thereof
12/18/2002EP1266001A2 Human transcription factors
12/18/2002EP1265995A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
12/18/2002EP1265989A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
12/18/2002EP1265928A1 Ultra high affinity neutralizing antibodies
12/18/2002EP1265924A2 Il-17 receptor like molecules and uses thereof
12/18/2002EP1265921A1 Charged compounds comprising a nucleic acid binding moiety and uses therefor
12/18/2002EP1265919A2 G-protein associated molecules
12/18/2002EP1265916A2 Therapeutic anti-cytomegalovirus compounds
12/18/2002EP1265913A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
12/18/2002EP1265909A2 Process for the preparation of 6-o-propargyl erythromycin derivatives
12/18/2002EP1265905A1 Il-8 receptor antagonists
12/18/2002EP1265900A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
12/18/2002EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/18/2002EP1265896A1 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
12/18/2002EP1265895A1 4-oxo-1,4-dihydro 1,8]naphthyridine-3-carboxamides as antiviral agents